Cite Filings / ESLA
Feed Companies Filings Check
Sign in

CIK 0001844417

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
861314502
Phone
+1 510-318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
Filings Financials Insiders Search text
All 260 Financials 86 Shareholder Meetings 5 Executive Compensation 73 Insider Trading 33 Beneficial Ownership Interest 22 Business Combinations 87 Public Offerings 74 Mutual Funds and ETFs 3 Others 20
›
Filed in
  1. No filings match these filters. Clear filters
  2. S-4 Deal Registration Statement - Business Combination 2022-10-18
  3. 8-K Event ▲ Auditor change 2022-10-11
  4. 8-K Event ● Material agreement · Regulation FD disclosure 2022-10-03
  5. 8-K Event ● Material agreement · New debt or obligation · Unregistered share sale 2022-07-27
  6. 8-K Event Other events 2021-09-03
  7. 8-K Event Other events 2021-07-22
  8. 8-K Event ● Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events 2021-07-19

Page 5 of 5 · 87 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…